A young Iranian cancer patient. Iranian scientists have successfully reduced the side effects of a cancer drug by infusing it with nanotechnology. Researchers at the Tabriz University of Medical Sciences discovered that the side effects of the drug Mitoxantrone could be reduced when the chemotherapeutic agent is infused with liposomic nanocarriers, which are created with cholesterol derivatives, IRNA...